Outcomes of critically ill COVID-19 patients boarding in the emergency department of a tertiary care center in a developing country: a retrospective cohort study

Table 3 Logistic regression: factors associated with mortality in COVID ICU patients

	aOR	95% C.I	p value
Pneumothorax or pneumomediastinum	20.77	[1.18, 364.28]	0.038
Age (> 65 years)	11.66	[1.59, 85.82]	0.016
Vasopressors	11.56	[1.44, 92.84]	0.021
Highflow	10.43	[1.14, 95.66]	0.038
Cardiovascular complications	10.33	[2.05, 52.11]	0.005
Severe CT	7.07	[1.34, 37.42]	0.021
Intubation	5.79	[1.23, 27.17]	0.026
Actemra	0.08	[0.02, 0.43]	0.003

Variables entered in the model: age (reference: ≤ 65 years old), O₂ triage (reference ≥ 95%), kidney disease (reference: no), vasopressors (reference: no), severe CT (reference: no), ARDS (reference: no), pneumothorax or pneumomediastinum (reference: no), acute kidney injury (reference: no), septic shock or DIC (reference: no), cardiovascular complications (reference: no), Actemra (reference: no), Remdesivir (reference: no), convalescent plasma (reference: no), antibiotics/antifungals/antivirals (reference: no), highflow (reference: no), intubation (reference: no), hemoglobin level, ABGs HCO₃, Troponin, and Procalcitonin
Omnibus test < 0.001, R² = 0.701, Hosmer = 0.882. Hyper-coagulopathy includes stroke, deep venous thrombosis (DVT), or pulmonary embolism (PE). Respiratory complications include ARDS, pneumothorax, respiratory failure, or pneumomediastinum. Other complications are metabolic acidosis, hemorrhage or cecal perforation, or rhabdomyolysis. Abbreviations: aOR adjusted odds ratio, 95%CI 95% confidence interval

ISSN: 1865-1380